{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:04:42Z","timestamp":1777673082315,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis (MPO-ANCA nephritis) is occasionally accompanied by lung abnormalities such as pulmonary fibrosis. However, the clinical features of pulmonary fibrosis in patients with MPO-ANCA nephritis have not been well documented. This study was performed to compare the prognosis of a usual interstitial pneumonia (UIP) pattern of lung fibrosis in patients with MPO-ANCA nephritis with the prognosis of idiopathic pulmonary fibrosis (IPF).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed the medical records of 126 patients with MPO-ANCA nephritis and identified 31 with a UIP pattern of lung fibrosis on high-resolution or thin-slice computed tomography (CT). We compared the characteristics and prognosis of these patients with those of 32 patients with IPF. In 18 patients from both groups, we assessed and compared the decline in lung volume over time using three-dimensional (3D) CT images reconstructed from thin-section CT data.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The numbers of male and female patients were nearly equal among patients with MPO-ANCA nephritis exhibiting a UIP pattern; in contrast, significant male dominancy was observed among patients with IPF (<jats:italic>p<\/jats:italic>\u00a0=\u20090.0021). Significantly fewer smokers were present among the patients with MPO-ANCA nephritis with a UIP pattern than among those with IPF (<jats:italic>p<\/jats:italic>\u00a0=\u20090.0062). There was no significant difference in the median survival time between patients with MPO-ANCA nephritis with a UIP pattern (50.8\u2009months) and IPF (55.8\u2009months; <jats:italic>p<\/jats:italic>\u00a0=\u20090.65). All patients with IPF in this cohort received antifibrotic therapy (pirfenidone or nintedanib). Almost half of the deaths that occurred in patients with MPO-ANCA nephritis with a UIP pattern were caused by non-respiratory-related events, whereas most deaths in patients with IPF were caused by respiratory failure such as acute exacerbation. In the 3D CT lung volume analyses, the rate of decline in lung volume was equivalent in both groups.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MPO-ANCA nephritis with a UIP pattern on CT may have an unfavorable prognosis equivalent to that of IPF with a UIP pattern treated with antifibrotic agents.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-019-0969-5","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T10:20:47Z","timestamp":1572603647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study"],"prefix":"10.1186","volume":"19","author":[{"given":"Toshikazu","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Minezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumito","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naozumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"969_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.11387","volume":"49","author":"C Agard","year":"2003","unstructured":"Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum. 2003;49:709\u201315.","journal-title":"Arthritis Rheum"},{"key":"969_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","volume":"42","author":"L Guillevin","year":"1999","unstructured":"Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42:421\u201330.","journal-title":"Arthritis Rheum"},{"key":"969_CR3","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar4550","volume":"16","author":"KE Sada","year":"2014","unstructured":"Sada KE, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014;16:R101.","journal-title":"Arthritis Res Ther"},{"key":"969_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/rheumatology\/kev286","volume":"55","author":"JH Schirmer","year":"2016","unstructured":"Schirmer JH, Wright MN, Vonthein R, Herrmann K, Nolle B, Both M, et al. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford). 2016;55:71\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"969_CR5","first-page":"20","volume":"7","author":"L Guillevin","year":"1995","unstructured":"Guillevin L, Lhote F. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol. 1995;7:20\u20134.","journal-title":"Curr Opin Rheumatol"},{"key":"969_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/qjmed\/hci015","volume":"98","author":"SE Lane","year":"2005","unstructured":"Lane SE, Watts RA, Shepstone L, Scott DG. Primary systemic vasculitis: clinical features and mortality. QJM. 2005;98:97\u2013111.","journal-title":"QJM."},{"key":"969_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2332\/allergolint.R-07-141","volume":"56","author":"S Ozaki","year":"2007","unstructured":"Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56:87\u201396.","journal-title":"Allergol Int"},{"key":"969_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/ard.2007.071936","volume":"67","author":"C Mukhtyar","year":"2008","unstructured":"Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67:1004\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"969_CR9","doi-asserted-by":"publisher","first-page":"i83","DOI":"10.1093\/ndt\/gfu385","volume":"30","author":"K Hirayama","year":"2015","unstructured":"Hirayama K, Kobayashi M, Usui J, Arimura Y, Sugiyama H, Nitta K. Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan. Nephrol Dial Transplant. 2015;30(Suppl 1):i83\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"969_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10157-012-0710-7","volume":"17","author":"S Homma","year":"2013","unstructured":"Homma S, Suzuki A, Sato K. Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist. Clin Exp Nephrol. 2013;17:667\u201371.","journal-title":"Clin Exp Nephrol"},{"key":"969_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.161224","volume":"44","author":"AJ Mohammad","year":"2017","unstructured":"Mohammad AJ, Mortensen KH, Babar J, Smith R, Jones RB, Nakagomi D, et al. Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: the influence of ANCA subtype. J Rheumatol. 2017;44:1458\u201367.","journal-title":"J Rheumatol"},{"key":"969_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Colby TV, Inoue Y, Nicholson AG, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med. 2018;6:138\u201353.","journal-title":"Lancet Respir Med"},{"key":"969_CR13","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remin-Jardin M, Myers JL, Richeldy L, Ryercon CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guidelines. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"969_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","volume":"9","author":"S Homma","year":"2014","unstructured":"Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2014;9:190\u20136.","journal-title":"Respirology."},{"key":"969_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","volume":"87","author":"M Chen","year":"2008","unstructured":"Chen M, Yu F, Zhang Y, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore). 2008;87:203\u20139.","journal-title":"Medicine (Baltimore)"},{"key":"969_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MD.0000000000000217","volume":"93","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Crestani B, Tazi A, Hervier B, Adam-Marchand S, Nunes H, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore). 2014;93:340\u20139.","journal-title":"Medicine (Baltimore)"},{"key":"969_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/resp.12763","volume":"21","author":"C Hosoda","year":"2016","unstructured":"Hosoda C, Baba T, Hagiwara E, Ito H, Matsuo N, Kitamura H, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology. 2016;21:920\u20136.","journal-title":"Respirology."},{"key":"969_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1183\/09031936.00110109","volume":"36","author":"GE Tzelepis","year":"2010","unstructured":"Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J. 2010;36:116\u201321.","journal-title":"Eur Respir J"},{"key":"969_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","volume":"190","author":"M Natsuizaka","year":"2014","unstructured":"Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med. 2014;190:773\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"969_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","volume":"157","author":"JA Bjoraker","year":"1998","unstructured":"Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199\u2013203.","journal-title":"Am J Respir Crit Care Med"},{"key":"969_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/ajrccm.164.7.2003140","volume":"164","author":"TE King Jr","year":"2001","unstructured":"King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001;164:1171\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"969_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/thx.53.6.469","volume":"53","author":"DW Mapel","year":"1998","unstructured":"Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax. 1998;53:469\u201376.","journal-title":"Thorax."},{"key":"969_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1164\/ajrccm.149.2.8306044","volume":"149","author":"DA Schwartz","year":"1994","unstructured":"Schwartz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994;149:450\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"969_CR24","first-page":"S17","volume":"23","author":"M Fisher","year":"2017","unstructured":"Fisher M, Nathan SD, Hill C, Marshall J, Dejonckheere F, Thuresson PO, et al. Predicting life expectancy for pirfenidone in idiopathic pulmonary fibrosis. J Manag Care Spec Pharm. 2017;23:S17\u201324.","journal-title":"J Manag Care Spec Pharm"},{"key":"969_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S2213-2600(16)30326-5","volume":"5","author":"SD Nathan","year":"2017","unstructured":"Nathan SD, Albera C, Bradford WZ, Costabel U, Glaspole I, Glassberg MK, et al. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Respir Med. 2017;5:33\u201341.","journal-title":"Lancet Respir Med"},{"key":"969_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.acra.2008.09.019","volume":"16","author":"S Iwano","year":"2009","unstructured":"Iwano S, Okada T, Satake H, Naganawa S. 3D-CT volumetry of the lung using multidetector row CT: comparison with pulmonary function tests. Acad Radiol. 2009;16:250\u20136.","journal-title":"Acad Radiol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0969-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:05:51Z","timestamp":1604102751000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0969-5","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The clinical data were retrieved from the electronic medical records with the endorsement of the Institutional Review Board of Fujita Health University (approval number HM-18-108).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; no personal information is presented in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no relationships that could be construed as a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}